2L-PCA: a two-level principal component analyzer for quantitative drug design and its applications.

Du, Qi-Shi; Wang, Shu-Qing; Xie, Neng-Zhong; Wang, Qing-Yan; Huang, Ri-Bo; Chou, Kuo-Chen

Du, Qi-Shi; Wang, Shu-Qing; Xie, Neng-Zhong; Wang, Qing-Yan; Huang, Ri-Bo; Chou, Kuo-Chen.

Afiliação

Du QS; State Key Laboratory of China for Biomass Energy Enzyme Technology, National Engineering Research Center of China for Non-Food Biorefinery, Guangxi Academy of Sciences, Nanning 530007, China.
Wang SQ; Gordon Life Science Institute, Boston, MA 02478, USA.
Xie NZ; School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
Wang QY; State Key Laboratory of China for Biomass Energy Enzyme Technology, National Engineering Research Center of China for Non-Food Biorefinery, Guangxi Academy of Sciences, Nanning 530007, China.
Huang RB; State Key Laboratory of China for Biomass Energy Enzyme Technology, National Engineering Research Center of China for Non-Food Biorefinery, Guangxi Academy of Sciences, Nanning 530007, China.
Chou KC; State Key Laboratory of China for Biomass Energy Enzyme Technology, National Engineering Research Center of China for Non-Food Biorefinery, Guangxi Academy of Sciences, Nanning 530007, China.

Oncotarget ; 8(41): 70564-70578, 2017 Sep 19.

Article em En | MEDLINE | ID: mdl-29050302

Palavras-chave

PCA; drug design; molecular fragments; peptides; physicochemical properties

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google